Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)
China · Delayed Price · Currency is CNY 99.98
-1.35 (-1.33%)
At close: Jan 27, 2026
SHE:002821 Revenue
Asymchem Laboratories (Tianjin) had revenue of 1.44B CNY in the quarter ending September 30, 2025, a decrease of -0.09%. This brings the company's revenue in the last twelve months to 6.29B, up 12.75% year-over-year. In the year 2024, Asymchem Laboratories (Tianjin) had annual revenue of 5.80B, down -25.82%.
Revenue (ttm)
6.29B
Revenue Growth
+12.75%
P/S Ratio
5.59
Revenue / Employee
655.99K
Employees
9,595
Market Cap
35.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.80B | -2.02B | -25.82% |
| Dec 31, 2023 | 7.83B | -2.40B | -23.51% |
| Dec 31, 2022 | 10.23B | 5.60B | 120.85% |
| Dec 31, 2021 | 4.63B | 1.50B | 47.67% |
| Dec 31, 2020 | 3.14B | 676.74M | 27.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pharmaron Beijing | 13.54B |
| Chongqing Zhifei Biological Products | 10.91B |
| Shanghai RAAS Blood Products | 7.95B |
| Beijing Tiantan Biological Products | 6.42B |
| Shanghai Allist Pharmaceuticals | 4.76B |
| Yili Chuanning Biotechnology | 4.74B |
| Hualan Biological Engineering | 4.27B |
| Xiamen Amoytop Biotech | 3.34B |